Autoimmune dermatologic toxicities from immune checkpoint blockade with anti-PD-1 antibody therapy: a report on bullous skin eruptions-Reference-Cited by-同舟云学术

Autoimmune dermatologic toxicities from immune checkpoint blockade with anti-PD-1 antibody therapy: a report on bullous skin eruptions

Published:2016-05-08 Issue:8 Volume:43 Page:688-696
ISSN:0303-6987
Container-title:Journal of Cutaneous Pathology
language:en
Short-container-title:J Cutan Pathol

Author:

Jour George¹,Glitza Isabella C.²,Ellis Rachel M.³,Torres-Cabala Carlos A.¹⁴,Tetzlaff Michael T.¹,Li Janet Y.³,Nagarajan Priyadharsini¹,Huen Auris²,Aung Phyu P.¹,Ivan Doina¹⁴,Drucker Carol R.²,Prieto Victor G.¹⁴,Rapini Ronald P.¹³⁴,Patel Anisha³⁴,Curry Jonathan L.¹⁴

Affiliation:

1. Department of Pathology, Section of Dermatopathology; The University of Texas MD Anderson Cancer Center; Houston TX USA

2. Department of Melanoma Medical Oncology; The University of Texas MD Anderson Cancer Center; Houston TX USA

3. Department of Dermatology; University of Texas Medical School; Houston TX USA

4. Department of Dermatology; The University of Texas MD Anderson Cancer Center; Houston TX USA

Publisher

Wiley

Subject

Dermatology,Histology,Pathology and Forensic Medicine

Reference14 articles.

1. Pembrolizumab versus Ipilimumab in Advanced Melanoma;Robert;N Engl J Med,2015

2. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma;Hamid;N Engl J Med,2013

3. Immune checkpoint blockade in cancer treatment: a double-edged sword cross-targeting the host as an "innocent bystander";Gelao;Toxins (Basel),2014

4. Risk of cutaneous toxicities in patients with solid tumors treated with immune checkpoint inhibitors: a meta-analysis;Abdel-Rahman;Future Oncol,2015

5. Pembrolizumab cutaneous adverse events and their association with disease progression;Sanlorenzo;JAMA Dermatol,2015

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune checkpoint inhibitor-induced cutaneous toxicities: a review of histopathologic and clinical features;Human Pathology;2023-10

2. The role of eosinophils in the differential diagnosis of inflammatory skin diseases;Human Pathology;2023-10

3. Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies;Cancers;2023-06-09

4. Oral mucosal toxicities induced by immune checkpoint inhibitors: Clinical features and algorithm management;Annales de Dermatologie et de Vénéréologie;2023-06

5. Gene expression profiling and multiplex immunofluorescence analysis of bullous pemphigoid immune‐related adverse event reveal upregulation of toll‐like receptor 4/complement‐induced innate immune response and increased density of T_H1 T‐cells;Journal of Cutaneous Pathology;2023-05-07